WallStreetZen

NYSE: ABT
Abbott Laboratories Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ABT

Based on 12 analysts offering 12 month price targets for Abbott Laboratories.
Min Forecast
$107.00-3.86%
Avg Forecast
$117.92+5.94%
Max Forecast
$130.00+16.8%

Should I buy or sell ABT stock?

Strong Buy
Strong Buy
11 analysts 78.57%
Buy
1 analysts 7.14%
Hold
2 analysts 14.29%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Forecast return on equity

Is ABT forecast to generate an efficient return?
Company
31.38%
Industry
28.91%
Market
62.25%
ABT's Return on Equity is forecast to be high in 4 years (31.38%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is ABT forecast to generate an efficient return on assets?
Company
14.36%
Industry
14.48%
Market
19.66%
ABT is forecast to generate lower Return on Assets (14.36%) than the US Medical Devices industry average (14.48%)
Forecast

ABT earnings per share forecast

What is ABT's earnings per share in the next 3 years based on estimates from 10 analysts?
Avg 1 year Forecast
$4.38+130.68%
Avg 2 year Forecast
$4.53+138.35%
Avg 3 year Forecast
$5.19+173.16%
ABT's earnings are forecast to grow at an exceptional rate of 37.78% per year
Forecast

ABT revenue forecast

What is ABT's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$38.6B+19.64%
Avg 2 year Forecast
$39.8B+23.39%
Avg 3 year Forecast
$43.0B+33.45%
ABT's revenue is forecast to grow at a rate of 9.43% per year, which is not exceptional
Forecast

ABT earnings growth forecast

How is ABT forecast to perform vs Medical Devices companies and vs the US market?
Company
37.78%
Industry
25.02%
Market
20.47%
ABT's earnings are forecast to grow faster (37.78% per year) than the US Medical Devices industry average (25.02%)
Forecast
ABT's earnings are forecast to grow faster (37.78% per year) than the US market average (20.47%)
Forecast
ABT's earnings are forecast to grow faster (37.78% per year) than the risk-free savings rate (1.1%)
Forecast

ABT revenue growth forecast

How is ABT forecast to perform vs Medical Devices companies and vs the US market?
Company
9.43%
Industry
10.41%
Market
14.48%
ABT's revenues are forecast to grow slower (9.43% per year) than the US Medical Devices industry average (10.41%)
Forecast
ABT's revenues are forecast to grow slower (9.43% per year) than the US market average (14.48%)
Forecast

Abbott Laboratories Stock Forecast FAQ

Is Abbott Laboratories Stock a good buy in 2020, according to Wall Street analysts?

The consensus among 14 Wall Street analysts covering (NYSE: ABT) stock is to Strong Buy ABT stock.

Out of 14 analysts, 11 (78.57%) are recommending ABT as a Strong Buy, 1 (7.14%) are recommending ABT as a Buy, 2 (14.29%) are recommending ABT as a Hold, 0 (0%) are recommending ABT as a Sell, and 0 (0%) are recommending ABT as a Strong Sell.

What is ABT's Price Target?

According to 12 Wall Street analysts that have issued a 1 year ABT price target, the average ABT price target is $117.92, with the highest ABT stock price forecast at $130.00 and the lowest ABT stock price forecast at $107.00.

On average, Wall Street analysts predict that Abbott Laboratories's share price could reach $117.92 by Jan 8, 2022. The average Abbott Laboratories stock price prediction forecasts a potential upside of 5.94% from the current ABT share price of $111.30.

What is ABT's earnings growth forecast for 2021-2023?

(NYSE: ABT) Abbott Laboratories's forecast annual earnings growth rate of 37.78% is forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 25.02%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 20.47%.

Abbott Laboratories's earnings in 2020 is $3,382,000,000.On average, 10 Wall Street analysts forecast ABT's earnings for 2021 to be $7,760,232,986, with the lowest ABT earnings forecast at $7,613,278,996, and the highest ABT earnings forecast at $7,896,563,796. On average, 7 Wall Street analysts forecast ABT's earnings for 2022 to be $8,018,022,153, with the lowest ABT earnings forecast at $7,436,225,996, and the highest ABT earnings forecast at $8,286,080,395.

In 2023, ABT is forecast to generate $9,189,050,695 in earnings, with the lowest earnings forecast at $9,082,818,895 and the highest earnings forecast at $9,295,282,495.

What is ABT's revenue growth forecast for 2021-2023?

(NYSE: ABT) Abbott Laboratories's forecast annual revenue growth rate of 9.43% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 10.41%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.48%.

Abbott Laboratories's revenue in 2020 is $32,221,000,000.On average, 7 Wall Street analysts forecast ABT's revenue for 2021 to be $68,254,652,067,160, with the lowest ABT revenue forecast at $67,633,502,339,200, and the highest ABT revenue forecast at $68,902,600,537,184. On average, 6 Wall Street analysts forecast ABT's revenue for 2022 to be $70,390,284,827,783, with the lowest ABT revenue forecast at $67,529,784,691,859, and the highest ABT revenue forecast at $72,809,505,148,877.

In 2023, ABT is forecast to generate $76,131,019,427,001 in revenue, with the lowest revenue forecast at $76,058,427,697,042 and the highest revenue forecast at $76,203,611,156,960.

What is ABT's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: ABT) Abbott Laboratories's current Earnings Per Share (EPS) is $1.90. On average, analysts forecast that ABT's EPS will be $4.38 for 2021, with the lowest EPS forecast at $4.30, and the highest EPS forecast at $4.46. On average, analysts forecast that ABT's EPS will be $4.53 for 2022, with the lowest EPS forecast at $4.20, and the highest EPS forecast at $4.68. In 2023, ABT's EPS is forecast to hit $5.19 (min: $5.13, max: $5.25).

What is ABT's forecast return on equity (ROE) for 2021-2024?

(NYSE: ABT) forecast ROE is 31.38%, which is considered strong.

What is ABT's forecast return on assets (ROA) for 2021-2024?

(NYSE: ABT) forecast ROA is 14.36%, which is lower than the forecast US Medical Devices industry average of 14.48%.
WallStreetZen
©2021 WallStreetZen
Company
AboutBlogPrivacy PolicyTerms of ServiceContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatistics
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics